Canada Pension Plan Investment Board Ptc Therapeutics, Inc. Transaction History

Canada Pension Plan Investment Board

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$33.53 - $54.79 $174,356 - $284,908	-5,200 Reduced 15.52%	28,300 $1.08 Million
Q3 2022 Nov 14, 2022	BUY	$41.85 - $53.85 $1.4 Million - $1.8 Million	33,500 New	33,500 $1.68 Million
Q1 2021 May 17, 2021	SELL	$46.8 - $68.92 $10.4 Million - $15.3 Million	-222,200 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$47.96 - $67.64 $10.7 Million - $15 Million	222,200 New	222,200 $13.6 Million
Q1 2020 May 13, 2020	SELL	$32.37 - $59.36 $1.82 Million - $3.34 Million	-56,183 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$32.22 - $50.07 $1.81 Million - $2.81 Million	56,183 New	56,183 $2.7 Million
Q2 2019 Aug 12, 2019	SELL	$35.42 - $45.0 $16,257 - $20,655	-459 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$28.09 - $39.49 $12,893 - $18,125	459 New	459 $17,000
Q4 2017 Feb 14, 2018	SELL	$15.14 - $20.89 $351,248 - $484,648	-23,200 Closed	0 $0
Q3 2017 Oct 30, 2017	SELL	$16.81 - $21.61 $292,494 - $376,014	-17,400 Reduced 42.86%	23,200 $464,000
Q1 2017 Jan 31, 2018	BUY	N/A	40,600	40,600 $400,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Canada Pension Plan Investment Board, based on Form 13F filings with the SEC.

Stay updated on Canada Pension Plan Investment Board with notifications on news.